Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$21.82
+3.24%
Mkt Cap $1.82B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$43.20
Range $30.00 – $56.00
Implied Upside
+98.0%
Consensus $43.20 vs current $21.82
NASDAQ·Healthcare·Biotechnology
$21.82
+3.24%
Mkt Cap $1.82B
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$43.20
Range $30.00 – $56.00
+98.0%
Consensus $43.20 vs current $21.82